These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21082949)

  • 1. Current strategies for the management of children with sickle cell disease.
    de Montalembert M
    Expert Rev Hematol; 2009 Aug; 2(4):455-63. PubMed ID: 21082949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?
    Bernaudin F
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):121-130. PubMed ID: 32202243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I manage cerebral vasculopathy in children with sickle cell disease.
    Brousse V; Kossorotoff M; de Montalembert M
    Br J Haematol; 2015 Sep; 170(5):615-25. PubMed ID: 25944412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology, prevention, and treatment of stroke in sickle cell disease.
    Wang WC
    Curr Opin Hematol; 2007 May; 14(3):191-7. PubMed ID: 17414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia.
    Mynarek M; Bettoni da Cunha Riehm C; Brinkmann F; Weißenborn K; Tell-Lüersen M; Heuft HG; Maecker-Kolhoff B; Sykora KW
    Klin Padiatr; 2013 May; 225(3):127-32. PubMed ID: 23625683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle Cell Disease and Stroke.
    Hirtz D; Kirkham FJ
    Pediatr Neurol; 2019 Jun; 95():34-41. PubMed ID: 30948147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.
    Kassim AA; DeBaun MR
    Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: role of transcranial Doppler ultrasound in stroke prophylaxis.
    Suliman H; Wali Y; Al Saadoon M; Zechariah M; William RR; Gujjar A; Pathare A
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):42-4. PubMed ID: 19125086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy.
    Minniti CP; Gidvani VK; Bulas D; Brown WA; Vezina G; Driscoll MC
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):626-30. PubMed ID: 15454832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
    Lefèvre N; Dufour D; Gulbis B; Lê PQ; Heijmans C; Ferster A
    Blood; 2008 Jan; 111(2):963-4; author reply 964. PubMed ID: 18182580
    [No Abstract]   [Full Text] [Related]  

  • 15. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
    Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
    Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease in children.
    Meier ER; Miller JL
    Drugs; 2012 May; 72(7):895-906. PubMed ID: 22519940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: a sickle cell center experience.
    Aloni MN; Nkee L
    Hemoglobin; 2014; 38(3):196-200. PubMed ID: 24669956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
    Adams RJ; Brambilla D;
    N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for primary stroke prevention in children with sickle cell anaemia.
    Jordan LC; Casella JF; DeBaun MR
    Br J Haematol; 2012 Apr; 157(1):14-25. PubMed ID: 22224940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.